Cargando…
Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study
Background: The systemic treatment of advanced cutaneous squamous cell carcinoma (cSCC) has seen significant developments in recent years. The anti-PD1 inhibitor cemiplimab has demonstrated efficacy in clinical trials, but real-world data are still limited. Here, we aimed to evaluate the efficacy an...
Autores principales: | Kuzmanovszki, Daniella, Kiss, Norbert, Tóth, Béla, Tóth, Veronika, Szakonyi, József, Lőrincz, Kende, Hársing, Judit, Kuroli, Enikő, Imrédi, Eleonóra, Kerner, Tünde, Patyánik, Mihály, Wikonkál, Norbert M., Szabó, Ákos, Brodszky, Valentin, Rencz, Fanni, Holló, Péter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531652/ https://www.ncbi.nlm.nih.gov/pubmed/37762907 http://dx.doi.org/10.3390/jcm12185966 |
Ejemplares similares
-
Anti-PD-1 Monotherapy in Advanced Melanoma—Real-World Data from a 77-Month-Long Retrospective Observational Study
por: Kuzmanovszki, Daniella, et al.
Publicado: (2022) -
Cutaneous malignancies in patients with Parkinson’s disease at a dermato-oncological university centre in Hungary
por: Tóth, Veronika, et al.
Publicado: (2023) -
Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters
por: Piros, Éva Anna, et al.
Publicado: (2021) -
Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
por: Király, Zsófia, et al.
Publicado: (2022) -
Optically Guided High-Frequency Ultrasound to Differentiate High-Risk Basal Cell Carcinoma Subtypes: A Single-Centre Prospective Study
por: Bozsányi, Szabolcs, et al.
Publicado: (2023)